Viewing Study NCT02077335


Ignite Creation Date: 2025-12-24 @ 10:36 PM
Ignite Modification Date: 2026-02-25 @ 4:59 PM
Study NCT ID: NCT02077335
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-02-21
First Post: 2014-02-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer
Sponsor: CSSS de Gatineau
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module